Company Quick10K Filing
Quick10K
Grifols
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
20-F 2018-12-31 Annual: 2018-12-31
20-F 2017-12-31 Annual: 2017-12-31
20-F 2016-12-31 Annual: 2016-12-31
20-F 2015-12-31 Annual: 2015-12-31

Grifols Financials

-

GRFS Metrics, Comps, Filings


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Quarter)

Operating, Investing, Financing

Comparables ($MM Annual) Ticker Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Advaxis ADXS 6 56 7 22 0 2 3 -36
Tonix Pharmaceuticals Holding TNXP 9 15 2 0 0 -24 -24 -4
Delmar Pharmaceuticals DMPI 3 4 2 0 0 8 8 -0
Diffusion Pharmaceuticals DFFN 2 19 3 0 0 -18 -18 -6
Phibro Animal Health PAHC 1 727 511 624 265 55 109 175
OHR Pharmaceutical OHRP 10 9 1 0 0 -10 -9 9
Zealand Pharma ZEAL
Therapix Biosciences TRPX 0 5 0 0 0 0 -2
Grifols GRFS 12,477 7,780 0 0 0 0 -592
AstraZeneca AZN 60,651 46,607 0 0 0 0 -893
Affimed AFMD 116 0 0 0 0 -0
Zomedica Pharmaceuticals ZOM 9 2 0 0 -24 -24 -6
Trillium Therapeutics TRIL 55 14 0 0 0 0 -0
Nabriva Therapeutics NBRV 679 84 40 3 0 -126 -123 629
VTV Therapeutics VTVT 9 22 11 0 -7 -4 6
Immtech Pharmaceuticals IMMP
Novo Nordisk NVO
Kiniksa Pharmaceuticals KNSA 308 33 0 0 -170 -170 -287
Bioblast Pharma ORPN 39 11 1 0 0 -3 -3 30
Intec Pharma NTEC 47 12 0 0 -21 -21 -21

Balance Sheet ($MM)2017-12-312018-12-31
Cash231592
Accounts Receivable
Inventory
PP&E
Assets10,92012,477
Accounts Payable
Long-Term Debt
Liabilities7,2867,780
Stockholders' Equity
Income Statement ($MM)2017-12-312018-12-31
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
Tax
Net Income
Cash Flow ($MM)2017-12-312018-12-31
Cash Operating
Cash Investing
Cash Financing